PersonalRX
Vaibhav Khullar has a diverse work experience in various roles and companies. Vaibhav currently serves as the Chief Technology Officer at PersonalRX - Your Pharmacy. Delivered. Since August 2020. Before that, they founded Bx in August 2017. Prior to that, they founded and served as the CEO of OSREC Technologies since 2011. In terms of their finance background, they worked at Credit Suisse from June 2013 to May 2017 in the Executive Risk Team. Vaibhav also had experience at Barclays Investment Bank as a Senior Consultant and in Global Financial Risk Management from 2012 to 2015. Vaibhav worked at Bank of America Merrill Lynch in Portfolio Management from 2011 to 2012, and at RBS Global Banking & Markets in Credit Default Swaps & Asset Backed Securities from 2010 to 2011.
Vaibhav Khullar attended Prince Henry's Grammar School from 1999 to 2006, where they completed their high school education. From 2006 to 2010, they attended the University of Oxford, majoring in MEng Engineering, Economics, and Management (Joint Honours).
This person is not in any offices
PersonalRX
PersonalRX offers personalized pharmacy services and free delivered dose packs making life safer and simpler for patients and caregivers. Our company began as GroupRX, recognizing the needs of organizations to more efficiently manage and dispense medications. By providing adherence packaging, excellent patient-centered customer service and coordinated data management, we've succeeded time and again. PersonalRX offers these services, including choice of personalized adherence packaging - proactive customer service that includes refill management - and technology that helps people simplify the process of managing medications. Our goal is to help reduce the dangers associated with polypharmacy (multiple prescriptions, often originating from multiple prescribers, potentially filled by multiple pharmacies). Polypharmacy is a dangerous part of our modern world - PersonalRX is a modern, easy, solution - and costs the same as using the corner pharmacy.